Global Oral Solid Dosage Excipients Growth Opportunities

Global Oral Solid Dosage Excipients Growth Opportunities

Frost & Sullivan’s analysis of the oral solid dosage excipients market aims at quantifying the consumption and analyzing the impact of key disruptive, transformative, and competitive trends across the value chain to present a forecast from 2022 to 2030. The study includes the analysis of the oral solid dosage excipients market based on key product types, sub-types, and geographies.

This research service analyzes the global oral solid dosage excipients market, covering North America, Europe, the Asia-Pacific (APAC), Latin America, and the Middle East & Africa (LAMEA). It details global and regional trends, market drivers and restraints and focuses on the oral solid dosage excipients used to formulate various drugs. The study includes the oral solid dosage excipients analysis based on key product segments of binders & fillers, coatings, disintegrants, glidants & lubricants, solubilizers, surfactants & emulsifiers, and others. It further quantifies the consumption of key sub-types within each of these product segments.

Expanding patient base and the need to develop targeted and effective therapies will drive market growth in the forecast period. Demand for patient-compliant drugs, such as orally disintegrating or rapidly disintegrating drugs, specifically for the aged population, has increased. It led to a surge in demand for excipients adaptable for such drugs. In addition, the growth in the end-use industry magnified by the trends, such as increasing chronic illnesses, rapidly aging population coupled with rising healthcare spending, and growing demand for multifunctional excipients, are estimated to drive market growth in the near future.

On the other hand, with an increasing number of pharmaceutical formulators using technologies to improve drug manufacturing efficiency, such as continuous manufacturing instead of batch manufacturing, the need for novel excipients is expected to rise over the forecast period.

The oral solid dosage excipients market has various global and regional participants. Companies focus on organic and inorganic growth strategies, with the expansion of product portfolios across geographies being a key growth strategy. Expanding the co-processed and multifunctional excipients portfolio remains a key area of focus.


  • Strategic Imperatives
    • Why is it Increasingly Difficult to Grow?
    • The Strategic Imperative 8™
    • The Impact of the Top Three Strategic Imperatives on Oral Solid Dosage Excipients
    • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Growth Opportunity Analysis—Oral Solid Dosage Excipients
    • Scope of Analysis
    • Growth Environment—Oral Solid Dosage Excipients
    • Market Segmentation by Product Type
    • Market Segmentation by Region
    • Market Definitions
    • Market Definitions—Binders and Fillers
    • Market Definitions—Coatings
    • Market Definitions—Disintegrants
    • Key Competitors
    • Forecast Assumptions—Oral Solid Dosage Excipients
    • Pharmaceutical Industry—Oral Solid Dosage Excipients
    • Trends in Pharmaceutical Industry
    • Pharmaceutical Excipients—Definition
    • Regulatory Landscape—Oral Solid Dosage Excipients
    • Value Chain—Oral Solid Dosage Excipients
    • Growth Drivers for Oral Solid Dosage Excipients
    • Growth Driver Analysis for Oral Solid Dosage Excipients
      • Table Oral Solid Dosage Excipients: Pharmaceutical Research and Development (R&D) Spending, Global, 2016–2024
    • Growth Restraints for Oral Solid Dosage Excipients
    • Growth Restraint Analysis for Oral Solid Dosage Excipients
  • Growth Opportunity Analysis—Oral Solid Dosage Excipients
    • Key Growth Metrics for Oral Solid Dosage Excipients
    • Revenue Forecast—Oral Solid Dosage Excipients
      • Table Oral Solid Dosage Excipients: Revenue Forecast, Global, 2019–2030
    • Revenue Forecast by Product Type—Oral Solid Dosage Excipients
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Product Type, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Oral Solid Dosage Excipient
    • Revenue Forecast by Region—Oral Solid Dosage Excipients
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Region, Global, 2019–2030
    • Revenue Forecast by Country—Oral Solid Dosage Excipients: North America
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Country, North America, 2019–2030
    • Revenue Forecast by Country—Oral Solid Dosage Excipients: Europe
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Country, Europe, 2019–2030
    • Revenue Forecast by Country—Oral Solid Dosage Excipients: APAC
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Country, APAC, 2019–2030
    • Revenue Forecast by Country—Oral Solid Dosage Excipients: LAMEA
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Country, LAMEA, 2019–2030
    • Revenue Forecast Analysis by Country—Oral Solid Dosage Excipients: North America
    • Revenue Forecast Analysis by Country—Oral Solid Dosage Excipients: Europe
    • Revenue Forecast Analysis by Country—Oral Solid Dosage Excipients: Asia-Pacific
    • Revenue Forecast Analysis by Country—Oral Solid Dosage Excipients: LAMEA
    • Net Compound Annual Growth Rate—Oral Solid Dosage Excipients
    • Competitive Environment—Oral Solid Dosage Excipients
    • Competitive Landscape—Oral Solid Dosage Excipients
    • Competitive Benchmarking—Oral Solid Dosage Excipients
    • Pricing Trends and Forecast Analysis—Oral Solid Dosage Excipients
  • Growth Opportunity Analysis—Binders & Fillers
    • Key Growth Metrics for Binders and Fillers
    • Revenue Forecast—Binders and Fillers
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Binders and Fillers, Global, 2019–2030
    • Revenue Forecast by Product Type—Binders and Fillers
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Product Type—Binders and Fillers Sub-Segment, Global, 2019–2030
    • Revenue Forecast by Product Type—Sugar Sub-segment
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Product Type—Sugar Sub-segment, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Binders and Fillers
  • Growth Opportunity Analysis—Coatings
    • Key Growth Metrics for Coatings
    • Revenue Forecast—Coatings
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Coatings, Global, 2019–2030
    • Revenue Forecast by Product Type—Coatings
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Product Type—Coatings Sub-Segment, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Coatings
  • Growth Opportunity Analysis—Disintegrants
    • Key Growth Metrics for Disintegrants
    • Revenue Forecast—Disintegrants
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Disintegrants, Global, 2019–2030
    • Revenue Forecast by Product Type—Disintegrants
      • Table Oral Solid Dosage Excipients: Revenue Forecast by Product Type—Disintegrants Sub-segments, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Disintegrants
  • Growth Opportunity Analysis—Glidants & Lubricants
    • Key Growth Metrics for Glidants and Lubricants
    • Revenue Forecast—Glidants and Lubricants
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Glidants and Lubricants, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Glidants and Lubricants
  • Growth Opportunity Analysis—Solubilizers, Surfactants, and Emulsifiers
    • Key Growth Metrics for Solubilizers, Surfactants, and Emulsifiers
    • Revenue Forecast—Solubilizers, Surfactants, and Emulsifiers
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Solubilizers, Surfactants, and Emulsifiers, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Solubilizers, Surfactants, and Emulsifiers
  • Growth Opportunity Analysis—Others
    • Key Growth Metrics for Others (Chelating Agents, Colors, and Flavors)
    • Revenue Forecast—Others (Chelating Agents, Colors, and Flavors)
      • Table Oral Solid Dosage Excipients: Revenue Forecast—Others, Global, 2019–2030
    • Revenue Forecast Analysis by Product Type—Others (Chelating Agents, Colors, and Flavors)
  • Growth Opportunity Universe
    • Growth Opportunity 1: An Independent Approval Pathway for Development of Novel Excipients will Augment Industry Growth
    • Growth Opportunity 2: The Rising Use of Multifunctional Excipients in Direct Compression will Support Oral Solid Dosage Industry
    • Growth Opportunity 3: Increasing Use of Solubility-enhancing Excipients Will Support Industry Growth
  • Next Steps
    • Your Next Steps
    • Why Frost, Why Now?

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings